Table 1.
Group information of three mouse models of NAFLD used in the study.
| Group | Strain | Treatment | Number of samples (n) |
|---|---|---|---|
| CON vs. Treatment | |||
| 1 | C57BL6/J WT | DEX for 2wks | 4 vs. 4 |
| 2 | C57BL6/J WT | HSHF for 12wks | 2 vs. 2 |
| 3 | C57BL6/J db/db | / | 4 vs. 4 |
Group information of three mouse models of NAFLD used in the study.
| Group | Strain | Treatment | Number of samples (n) |
|---|---|---|---|
| CON vs. Treatment | |||
| 1 | C57BL6/J WT | DEX for 2wks | 4 vs. 4 |
| 2 | C57BL6/J WT | HSHF for 12wks | 2 vs. 2 |
| 3 | C57BL6/J db/db | / | 4 vs. 4 |